Concepedia

Lucila Nassif Kerbauy

LN

23

Publications

3.3K

Citations

19

H-Index

2010

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Hospital Israelita Albert Einstein

Universidade de São Paulo

Affimed Therapeutics (Germany)

University of Houston

Lucila Nassif Kerbauy is an author at The University of Texas MD Anderson Cancer Center specializing in immunology, medicine, and cell biology.

ORCID

Top concepts

Publications per year

2010–2025

23

Publications

23

Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

Enli Liu, David Marín, Pinaki P. Banerjee et al. · New England Journal of Medicine · 2020 · 2K citations · Full text

Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells

May Daher, Rafet Başar, Elif Gokdemir et al. · Blood · 2020 · 272 citations · Full text

Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells

Hila Shaim, Mayra Shanley, Rafet Başar et al. · Journal of Clinical Investigation · 2021 · 234 citations · Full text

, , +28

KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape

Ye Li, Rafet Başar, Guohui Wang et al. · Nature Medicine · 2022 · 152 citations · Full text

, , +10

Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies

Lucila Nassif Kerbauy, Nancy D. Marín, Mecit Kaplan et al. · Clinical Cancer Research · 2021 · 147 citations · Full text

Rows per page

1–5 of 23